Literature DB >> 22681909

Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells.

Zu-Yau Lin1, Wan-Long Chuang.   

Abstract

The common genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma (HCC) cells were investigated. Primary cultured HCC cells from three patients were separated by Matrigel invasion into parent and invasive cells. Whole human genome oligo microarray was applied to detect the differentially expressed genes in invasive cells. A purchased HCC cell line (HA 22T/VGH) was studied for comparison. Forty genes were consistently up-regulated and 14 genes were consistently down-regulated among primary cultured invasive cells. Among these genes, only three up-regulated genes (CNN1, PLAT, SPARC) and one down-regulated tumor suppressor gene (MDFI) had same expressions in invasive cells originated from purchased cell line. For primary cultured invasive cells, differential expressions of several groups of common genes are known to have capacities to promote proliferation (CAV1, IL6, PLAT, RRAD, SRPX), remodeling of extracellular matrix (COL1A1, COL1A2, NID2, TNC, RELN, SPARC), migration (ACTG2, CAV1, CCL2, CCL26, CDC42EP3, CNN1, PHLDB2, PLAT, RRAD, SRPX), implantation (IL6), immune escape (CD70) and angiogenesis (CCL2, IL6, IL18, PLAT, SLIT3). Two genes related to signal transduction (AXL, RASL10B) and one related to metabolism (PTGS2) also showed consistent expressions. Differential expressions of these genes are capable for tumor invasiveness. In conclusion, the characteristics of invasive phenotype HCC cells are originated from differential expressions of several groups of genes rather than few target genes. This information may give us a new insight to design new stratagems in HCC treatment. Analysis of the results from a purchased cell line may have bias due to long-term repeated in vitro cultures.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22681909     DOI: 10.1016/j.biopha.2012.04.001

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  34 in total

1.  Analysis of long non-coding RNA expression profiles in gastric cancer.

Authors:  Wei-Jun Cao; Hai-Lu Wu; Bang-Shun He; Yu-Shu Zhang; Zhen-Yu Zhang
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

2.  Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.

Authors:  Lu Zhang; Xiaoqiao Liu; Xuegong Zhang; Ronghua Chen
Journal:  Mol Genet Genomics       Date:  2015-12-28       Impact factor: 3.291

3.  Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer.

Authors:  Shameem Fawdar; Eleanor W Trotter; Yaoyong Li; Natalie L Stephenson; Franziska Hanke; Anna A Marusiak; Zoe C Edwards; Sara Ientile; Bohdan Waszkowycz; Crispin J Miller; John Brognard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

4.  Experimental validation of 5 in-silico predicted glioma biomarkers.

Authors:  Rheal A Towner; Randy L Jensen; Brian Vaillant; Howard Colman; Debra Saunders; Cory B Giles; Jonathan D Wren
Journal:  Neuro Oncol       Date:  2013-10-24       Impact factor: 12.300

5.  Identification of hub genes and pathways in bladder cancer using bioinformatics analysis.

Authors:  Danhui Li; Fan Zhen; Jianwei Le; Guodong Chen; Jianhua Zhu
Journal:  Am J Clin Exp Urol       Date:  2022-02-15

Review 6.  The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

Authors:  Catalina Atorrasagasti; Agostina M Onorato; Guillermo Mazzolini
Journal:  J Physiol Biochem       Date:  2022-08-26       Impact factor: 5.080

7.  Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.

Authors:  Nassima Benzoubir; Charlotte Mussini; Charlène Lejamtel; Alexandre Dos Santos; Claire Guillaume; Christophe Desterke; Didier Samuel; Christian Bréchot; Marie-Françoise Bourgeade; Catherine Guettier
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

8.  B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.

Authors:  A Inoue; K Okamoto; Y Fujino; T Nakagawa; N Muguruma; K Sannomiya; Y Mitsui; T Takaoka; S Kitamura; H Miyamoto; T Okahisa; T Fujimori; I Imoto; T Takayama
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640

9.  Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes.

Authors:  S U Lauvrak; E Munthe; S H Kresse; E W Stratford; H M Namløs; L A Meza-Zepeda; O Myklebost
Journal:  Br J Cancer       Date:  2013-09-24       Impact factor: 7.640

10.  Identification of the collagen type 1 α 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma.

Authors:  Masamichi Hayashi; Shuji Nomoto; Mitsuhiro Hishida; Yoshikuni Inokawa; Mitsuro Kanda; Yukiyasu Okamura; Yoko Nishikawa; Chie Tanaka; Daisuke Kobayashi; Suguru Yamada; Goro Nakayama; Tsutomu Fujii; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Shin Takeda; Yasuhiro Kodera
Journal:  BMC Cancer       Date:  2014-02-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.